Skip to main content
BEAMTREE HOLDINGS LIMITED logo

BEAMTREE HOLDINGS LIMITED — Investor Relations & Filings

Ticker · BMT ISIN · AU0000170979 LEI · 9845001D2843E1577F22 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 384 across all filing types
Latest filing 2020-04-19 Regulatory Filings
Country AU Australia
Listing ASX BMT

About BEAMTREE HOLDINGS LIMITED

https://beamtree.com.au/

Beamtree Holdings Limited provides health data technology solutions focused on clinical decision support, data analytics, and performance benchmarking. The company develops software to enhance patient safety and operational efficiency within healthcare environments. Its primary product, RippleDown, automates expert clinical knowledge to provide real-time decision support in pathology and diagnostic settings. Additionally, the Ainsoff Index offers predictive analytics for early clinical intervention by monitoring patient deterioration. Through its benchmarking platforms, the company enables health services to analyze and compare clinical outcomes and resource utilization. Beamtree focuses on the integration of data-driven insights into clinical workflows to minimize risk and improve the quality of care delivery.

Recent filings

Filing Released Lang Actions
Trading Halt 2 pages 186.3KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from PKS Holdings Limited regarding a trading halt requested pending the release of an announcement about a material acquisition. It references ASX Listing Rule 17.1 and specifies the halt is until the announcement or a certain date. There is no financial data, report, or detailed disclosure here—only a regulatory announcement about trading status related to an upcoming acquisition announcement. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not contain the acquisition details themselves or financial statements.
2020-04-19 English
PKS Investor Update Conference Call 21 April 2020 1
Call Transcript Classification · 90% confidence The document is an ASX announcement dated 20 April 2020 from PKS Holdings Limited, notifying about an upcoming investor conference call scheduled for 21 April 2020. It provides registration and dial-in details for the call but does not contain any financial data, report content, or detailed analysis. The document is short (1703 characters) and serves as a notice for the call rather than the transcript or report itself. Therefore, it fits the category of a Call Transcript announcement or invitation, but since it is only an announcement of the call and not the transcript, the best fitting category is Call Transcript (CT) as it relates to the conference call content. Confidence is high given the clear context and content type.
2020-04-19 English
PKS renews agreement with 3rd largest pathology provider 1
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 17 April 2020 from PKS Holdings Limited about signing a renewal agreement for a software license and support with a private pathology provider. It is a brief announcement about a contract renewal and does not contain financial statements, management discussion, or detailed financial data. The document length is short (2188 characters) and it is clearly an announcement of a business update rather than a report or detailed filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not related to board changes, voting results, or capital changes. The best fitting category is Regulatory Filings (RNS), which is the fallback for general regulatory announcements and business updates that do not fit other specific categories.
2020-04-16 English
Clarification on Renewal of Agreement 1 page 140.3K
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 17 April 2020 from PKS Holdings Limited. It announces the signing of a renewal agreement with a customer, Australian Clinical Laboratories, for a software license and support agreement. The content focuses on a business update regarding a contract renewal, with no financial statements, regulatory certifications, or detailed financial data. The document is short (2338 characters) and is clearly an announcement of a business event rather than a report or detailed financial filing. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to a contract renewal impacting company operations and revenue streams, but not a financing event per se. However, since it is a business update about a contract renewal and not about fundraising or capital structure changes, the closest fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2020-04-16 English
PKS signs renewal agreement with Healthscope NZ 1 p
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement dated 17 April 2020 from PKS Holdings Limited regarding the signing of a renewal agreement with Healthscope NZ for a software license and support. The content focuses on a contract renewal and does not contain financial statements, management discussion, or regulatory certifications. The document length is short (2096 characters) and is clearly an announcement of a business agreement rather than a financial report or regulatory filing. Therefore, it fits best under the category of Capital/Financing Update (CAP) as it relates to a business contract renewal impacting company operations and potentially its financial position.
2020-04-16 English
PKS business update in response to COVID-19 2 pages 126.2KB
Regulatory Filings Classification · 90% confidence The document is an ASX announcement dated 30 March 2020 from PKS Holdings Limited providing a business update in response to the COVID-19 pandemic. It discusses the company's operational status, financial highlights such as cash balance and EBITDA, and the impact of COVID-19 on its business. The document does not contain detailed financial statements or comprehensive financial analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It is a narrative update focusing on business conditions and outlook rather than a formal financial report. The length is about 5561 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the document fits best as a Capital/Financing Update (CAP) or a Regulatory Filing (RNS). Since it primarily provides a business update related to COVID-19 impacts and financial position without new financing or capital structure changes, it is best classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous announcements that do not fit other categories.
2020-03-29 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.